Our thought leaders and specialist consultants have a wealth of case studies, news, and blog articles to check out.
Randomized controlled trials often have restrictive inclusion criteria, resulting in trial participants who do not represent the real-world population
Introduction As the cornerstone of advancing medical science, clinical trials require broad diversity among...
Matt Lewis, the Global Chief Officer for Artificial and Augmented Intelligence at Inizio Medical, has been featured alongside Richard Graves from...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical, took part in a recent podcast with CPO playbook regarding...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical has joined a recent discussion on GOLD’s ‘2024 pharma...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical, contributed to a recent piece in the Current Medical...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical, and Will Reese, Chief Innovation Officer at Evoke, an...
In the dynamic landscape of modern business, regulated industries stand at a critical juncture as emerging technologies like generative AI present...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer at Inizio Medical, joins the Global Alliance for Medical Education (GAME) on...
Matt Lewis, Global Chief Artificial and Augmented Intelligence Officer, and David Woods, Vice President leading the Medical Analytics and...
In the latest in a series of high-profile collaborations with leading industry bodies, Inizio Medical has played a crucial role in the development...
A newly published AI roadmap, co-authored by the Healthcare Communications Association (HCA) and Inizio Medical’s Global Chief Artificial and Augmente